Application 204845
- Type
- ANDA
- Sponsor
- SAGENT PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | UNKNOWN | UNKNOWN | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Baxter Healthcare Corporation | 3ed3e0a9-a0a8-4555-9f73-2043e79e3398 | 2026-05-29 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE |
| FOCINVEZ | FOSAPREPITANT DIMEGLUMINE | Amneal Pharmaceuticals LLC | 7afe33d8-5416-465a-b98b-f4eedc327a94 | 2026-04-17 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Camber Pharmaceuticals, Inc. | 7dbdf8f5-6936-4143-b52d-96774b799a7d | 2026-04-14 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Eugia US LLC | 19919480-960b-4741-9611-c133d68512f5 | 2026-04-01 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE FOSAPREPITANT DIMEGLUMINE |
| FOCINVEZ | FOSAPREPITANT DIMEGLUMINE | Steriscience Specialties Private Limited | 18a60093-cec8-1b8c-e063-6394a90a8902 | 2026-03-30 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Hikma Pharmaceuticals USA Inc. | 1a7d2f44-b578-4d99-a4ff-f267626064d0 | 2026-03-19 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE FOSAPREPITANT DIMEGLUMINE |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Hikma Pharmaceuticals USA Inc. | 1cc7d482-5d45-4621-9ffc-cd3f7c54614d | 2026-03-19 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE FOSAPREPITANT DIMEGLUMINE |
| EMEND | FOSAPREPITANT DIMEGLUMINE | Merck Sharp & Dohme LLC | 8d66803a-6811-4c29-9c57-e16acfa87f21 | 2026-02-20 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE |
| FOSAPREPITANT | FOSAPREPITANT DIMEGLUMINE | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 7375ab3f-a6fc-4601-9415-07b4f681cdef | 2025-12-24 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Qilu Pharmaceutical Co., Ltd. | 5bb41bcb-c775-4447-9bd0-d4c55ad110ea | 2025-08-07 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE FOSAPREPITANT DIMEGLUMINE |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Avenacy, LLC | 3f942e4c-e26a-4155-9e14-344b2970b189 | 2025-07-09 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | BluePoint Laboratories | 2d30d839-bb88-46ce-a9ed-66fe32a12a7a | 2025-07-07 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | NorthStar RxLLC | df341f63-0fef-4411-a89b-6df6b9e792be | 2023-07-25 | Warnings, Adverse reactions | FOSAPREPITANT DIMEGLUMINE |